Accademia di Architettura, Mendrisio, presso l'edificio Canavée.

l tema dell'evento è:

Life sciences: il business della complessità

• Mappatura tecnologica delle presentazioni

• Mappatura tecnologica dell'evento

The theme of the event is:

Life sciences: the business of complexity

• Technologial map of the presenting companies

• Technological map of the event

Opening remarks: Arnoldo Coduri, Economics and Finance Department of Canton Tessin.

Key note lecture:
DNA: an economist's perspective, Giovanni Barone-Adesi, Prof USI.

Therapeutic vaccines for HCV, Andreas Cerny, EOC and Prof Uni Bern.

MondoBiotech,
"Goal: mondoBIOTECH specializes in combating fatal and rare lung diseases. We work to provide safe and effective medicines to patients with severe and rare lung diseases", Dorian Bevec, CSO

Nikem SpA,
"NiKem Research, a potent drug discovery partner", Carlo Farina CEO.

Evolva Bio,
"Genetic Chemistry: Evolving and Improving Small Molecule Drugs", Melya Hughes Crameri, VP Alliances & Intellectual Property.

Areta International,
"Cells as source for the biodrugs of the future", Maria Luisa Nolli, CEO.

Esbatech SA,
"Advancing Antibody Fragment Therapeutics", Dominik Escher, CEO.

Solvias SA,
"Biopharmaceutical analysis at Solvias", Erik Hahn, Director Bioanalytical Services.

Merck & Co,
"Big Pharma and Biotech: United we stand, divided we fall", Margaret Beer, Director Licensing and External Research, EU.

Hoffmann-La Roche Ltd.,
"Innovation, Biotech, and the Roche Innovation Model", Uwe Meya, Head of Research Portfolio Management.

Cardinal Health,
"Cardinal Health: from early development to commercial manufacturing", Lorenzo Pradella Director Business Development.

SWX,
"Life Sciences on SWX Swiss Exchange. The swiss stock Exchange is one of the leading platform in Europe to finance bio and medtech companies", Philippe Jean Allamel, VP Issuer and Investor Relations.

Biovalley,
"BioValley, a unique trinational Bioregion", Romeo Paioni, Novartis Pharma, Head Scientific and External Affairs.

Assegnazione del premio ASIRB/Roche.